首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Polyphenol-Rich Fraction of Brown Alga Ecklonia cava Collected from Gijang Korea Reduces Obesity and Glucose Levels in High-Fat Diet-Induced Obese Mice
【2h】

Polyphenol-Rich Fraction of Brown Alga Ecklonia cava Collected from Gijang Korea Reduces Obesity and Glucose Levels in High-Fat Diet-Induced Obese Mice

机译:从韩国Gijang收集的褐藻Ecklonia cava的富含多酚的馏分可降低高脂饮食诱导的肥胖小鼠的肥胖和葡萄糖水平

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ecklonia cava (E. cava) is a brown alga that has beneficial effects in models of type 1 and type 2 diabetes. However, the effects of E. cava extracts on diet-induced obesity and type 2 diabetes have not been specifically examined. We investigated the effects of E. cava on body weight, fat content, and hyperglycemia in high-fat diet- (HFD) induced obese mice and sought the mechanisms involved. C57BL/6 male mice were fed a HFD (60% fat) diet or normal chow. After 3 weeks, the HFD diet group was given extracts (200 mg/kg) of E. cava harvested from Jeju (CA) or Gijang (G-CA), Korea or PBS by oral intubation for 8 weeks. Body weights were measured weekly. Blood glucose and glucose tolerance were measured at 7 weeks, and fat pad content and mRNA expression of adipogenic genes and inflammatory cytokines were measured after 8 weeks of treatment. G-CA was effective in reducing body weight gain, body fat, and hyperglycemia and improving glucose tolerance as compared with PBS-HFD mice. The mRNA expression of adipogenic genes was increased, and mRNA expression of inflammatory cytokines and macrophage marker gene was decreased in G-CA-treated obese mice. We suggest that G-CA reduces obesity and glucose levels by anti-inflammatory actions and improvement of lipid metabolism.
机译:Ecklonia cava(E. cava)是一种褐藻,在1型和2型糖尿病模型中具有有益作用。但是,大肠杆菌提取物对饮食引起的肥胖症和2型糖尿病的作用尚未得到专门研究。我们调查了大肠杆菌对高脂饮食(HFD)诱导的肥胖小鼠体重,脂肪含量和高血糖的影响,并探讨了涉及的机制。给C57BL / 6雄性小鼠喂食HFD(60%脂肪)饮食或正常食物。 3周后,HFD饮食组接受了从济州(CA)或吉江(G-CA),韩国或PBS收获的大肠埃希菌的提取物(200μmg/ kg),持续8周。每周测量体重。治疗7周后测量血糖和葡萄糖耐量,并测量脂肪垫含量,成脂基因和炎性细胞因子的mRNA表达。与PBS-HFD小鼠相比,G-CA可有效减少体重增加,体内脂肪和高血糖症,并改善葡萄糖耐量。在G-CA处理的肥胖小鼠中,脂肪形成基因的mRNA表达增加,炎性细胞因子和巨噬细胞标记基因的mRNA表达降低。我们建议,G-CA可通过抗炎作用和改善脂质代谢来降低肥胖症和血糖水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号